Resverlogix Corp RVXCF

Primary Symbol: T.RVX

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp > Stock symbol change

<< Previous

Bullboard Posts

Next >>

Comment by fuzzyjron Jun 28, 2024 3:35pm

201 Views

Post# 36111342

RE:Stock symbol change

If this ceo wasn't protected under the forward looking statement clause/rules he would be in jail imo. The very least he would have been fired years ago. What in the Frick do they do around there ,
week in week out -
month in month out heck year in & year out??? Scabby run operation in anyone's opinion.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing